Author

Alexander Marin

Institute for Bioscience and Biotechnology ResearchORCID 0000-0002-2194-8170Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Alexander K. AndrianoviD· 2 shared Eric A. TothiD· 2 shared Kinlin L. ChaoiD· 2 shared Liudmila Kulakova· 2 shared Thomas R. FuerstiD· 2 shared Alexander PloßiD· 1 shared Austin W.T. ChiangiD· 1 shared Bhoj KumariD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Alexander K. AndrianovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Incorporation of native HCV E1E2 into a nanoparticle vaccine platform

Liudmila Kulakova, Sarah Jeong, Dong-Xiu Zhang, Xiaoran Shang, Kinlin L. Chao, Alexander Marin, Matthew C. Metcalf, Tagide deCarvalho, Edwin Pozharski, Yuxing Li, Brian G. Pierce, Alexander K. Andrianov, Eric A. Toth, Thomas R. Fuerst

This paper develops a nanoparticle vaccine platform incorporating native HCV E1E2 to enhance immunogenicity, showing improved neutralizing antibody responses compared to subunit vaccines.

bioRxiv · Aug 6, 2026 · PreprintMicrobiology

Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicity

Liudmila Kulakova, Kiki H. Li, Austin W.T. Chiang, Michael P. Schwoerer, Sanne Schoffelen, Khadija H. Elkholy, Kinlin L. Chao, Salman Shahid, Bhoj Kumar, Nathan B. Murray, Stephanie A. Archer‐Hartmann, Parastoo Azadi, Bjørn Gunnar Rude Voldborg, Alexander Marin, Roy A. Mariuzza, , Thomas R. Fuerst

This study shows that glycoengineering of HCV E2 glycoprotein affects antigen biochemical properties and immune response, with some glycans improving neutralization potency.

bioRxiv · Apr 2, 2025 · PreprintImmunology